Repligen is listed on NASDAQ Global Markets under the ticker RGEN.
Repligen began trading on the NASDAQ May 6, 1986 under the ticker RGEN.
If you hold your shares in a brokerage account, please contact your broker.
If you hold your stock certificates directly, please contact our transfer agent, American Stock Transfer & Trust Company with your question or to provide your new contact information.
American Stock Transfer & Trust Company
59 Maiden Lane
Plaza Level
New York, NY 10038
Phone: 877.777.0800, select option 1
Web:
www.amstock.com
No, Repligen does not have a direct purchase program. You may purchase stock through a brokerage.
Repligen has not historically paid cash dividends on our common stock and we do not anticipate paying cash dividends in the foreseeable future. We are focused on building value for shareholders through reinvestment in programs and products aimed at delivering sustainable profitability and optimizing earnings margins.
As of January 1, 2012, our fiscal year ends on December 31 of each calendar year. Previously the Company's fiscal year ended on March 31 of each year.
As of June 30, 2012, we had 30.8 million common shares outstanding (33.5 million fully diluted).
Cash and marketable securities as of June 30, 2012 was $39 million, excluding restricted cash.
Repligen has estimated the following for fiscal year 2012, ending December 31, 2012; $55 to $57 million in revenue (of which $41 to $43 million is bioprocessing product revenue), and $5.0 to $7.0 million in net income.
Repligen was incorporated in May 1981 in Delaware.
Repligen’s principle executive offices are located in Waltham, Massachusetts. We have additional manufacturing facilities in Lund, Sweden.
As of June 30, 2012, Repligen had 130 employees.
Yes. Repligen currently markets a line of bioprocessing products, including Protein A, which is used by pharmaceutical companies in the production of monoclonal antibodies. Additional bioprocessing products marketed by Repligen include growth factors used to increase productivity in cell culture, as well as OPUS(TM) pre-packed chromatography columns and media, used for biologics purification.
